Literature DB >> 18785124

Ets transcription factors in intestinal morphogenesis, homeostasis and disease.

Paul Jedlicka1, Arthur Gutierrez-Hartmann.   

Abstract

Ets transcription factors comprise a large family of sequence-specific regulators of gene expression with important and diverse roles in development and disease. Most Ets family members are expressed in the developing and/or mature intestine, frequently in a compartment-specific and temporally dynamic manner. However, with the exception of the highly expressed Elf3, involved in embryonic epithelial differentiation, little is known about Ets functions in intestinal development and homeostasis. Ets factors show altered expression in colon cancer, where they regulate pathways relevant to tumor progression. Ets factors also likely act as important modifiers of non-neoplastic intestinal disease by regulating pathways relevant to tissue injury and repair. Despite a large body of published work on Ets biology, much remains to be learned about the precise functions of this large and diverse gene family in intestinal morphogenesis, homeostasis, and both neoplastic and non-neoplastic pathology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18785124      PMCID: PMC2716142          DOI: 10.14670/HH-23.1417

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  88 in total

1.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Authors:  Scott A Tomlins; Daniel R Rhodes; Sven Perner; Saravana M Dhanasekaran; Rohit Mehra; Xiao-Wei Sun; Sooryanarayana Varambally; Xuhong Cao; Joelle Tchinda; Rainer Kuefer; Charles Lee; James E Montie; Rajal B Shah; Kenneth J Pienta; Mark A Rubin; Arul M Chinnaiyan
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

2.  Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic patterning.

Authors:  Martyn Donnison; Angela Beaton; Helen W Davey; Ric Broadhurst; Phil L'Huillier; Peter L Pfeffer
Journal:  Development       Date:  2005-04-13       Impact factor: 6.868

3.  The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.

Authors:  H C Crawford; B Fingleton; M D Gustavson; N Kurpios; R A Wagenaar; J A Hassell; L M Matrisian
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

4.  Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation.

Authors:  Jiong Zhou; Renee Chehab; Josephine Tkalcevic; Matthew J Naylor; Jessica Harris; Trevor J Wilson; Sue Tsao; Irene Tellis; Silva Zavarsek; Dakang Xu; Erika J Lapinskas; Jane Visvader; Geoffrey J Lindeman; Ross Thomas; Christopher J Ormandy; Paul J Hertzog; Ismail Kola; Melanie A Pritchard
Journal:  EMBO J       Date:  2005-01-13       Impact factor: 11.598

5.  Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease.

Authors:  Duncheng Wang; Shinu A John; James L Clements; Dean H Percy; Kevin P Barton; Lee Ann Garrett-Sinha
Journal:  Int Immunol       Date:  2005-07-28       Impact factor: 4.823

6.  Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF).

Authors:  Maina Lepourcelet; Liqiang Tou; Li Cai; Jun-ichi Sawada; Alexander J F Lazar; Jonathan N Glickman; Jessica A Williamson; Allen D Everett; Mark Redston; Edward A Fox; Yoshihiro Nakatani; Ramesh A Shivdasani
Journal:  Development       Date:  2004-12-16       Impact factor: 6.868

7.  ERM is required for transcriptional control of the spermatogonial stem cell niche.

Authors:  Chen Chen; Wenjun Ouyang; Vadim Grigura; Qing Zhou; Kay Carnes; Hyunjung Lim; Guang-Quan Zhao; Silvia Arber; Natasza Kurpios; Theresa L Murphy; Alec M Cheng; John A Hassell; Varadaraj Chandrashekar; Marie-Claude Hofmann; Rex A Hess; Kenneth M Murphy
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

8.  Reduced expression and tumor suppressor function of the ETS transcription factor ESE-3 in prostate cancer.

Authors:  R Cangemi; A Mensah; V Albertini; A Jain; M Mello-Grand; G Chiorino; C V Catapano; G M Carbone
Journal:  Oncogene       Date:  2007-11-26       Impact factor: 9.867

9.  Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome.

Authors:  Thomas E Sussan; Annan Yang; Fu Li; Michael C Ostrowski; Roger H Reeves
Journal:  Nature       Date:  2008-01-03       Impact factor: 49.962

10.  Ets-1 confers cranial features on neural crest delamination.

Authors:  Eric Théveneau; Jean-Loup Duband; Muriel Altabef
Journal:  PLoS One       Date:  2007-11-07       Impact factor: 3.240

View more
  23 in total

1.  Altered intestinal epithelial homeostasis in mice with intestine-specific deletion of the Krüppel-like factor 4 gene.

Authors:  Amr M Ghaleb; Beth B McConnell; Klaus H Kaestner; Vincent W Yang
Journal:  Dev Biol       Date:  2010-11-09       Impact factor: 3.582

Review 2.  Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer.

Authors:  Daisuke Kyuno; Hiroshi Yamaguchi; Tatsuya Ito; Tsuyoshi Kono; Yasutoshi Kimura; Masafumi Imamura; Takumi Konno; Koichi Hirata; Norimasa Sawada; Takashi Kojima
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  Ets transcription factors control epithelial maturation and transit and crypt-villus morphogenesis in the mammalian intestine.

Authors:  Paul Jedlicka; Xiaomei Sui; Lori Sussel; Arthur Gutierrez-Hartmann
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

4.  Mutant K-Ras increases GSK-3β gene expression via an ETS-p300 transcriptional complex in pancreatic cancer.

Authors:  J-S Zhang; A Koenig; A Harrison; A V Ugolkov; M E Fernandez-Zapico; F J Couch; D D Billadeau
Journal:  Oncogene       Date:  2011-03-28       Impact factor: 9.867

5.  Analysis of select members of the E26 (ETS) transcription factors family in colorectal cancer.

Authors:  Candida Deves; Daiana Renck; Bernardo Garicochea; Vinicius Duval da Silva; Tiago Giulianni Lopes; Henrique Fillman; Lucio Fillman; Silvana Lunardini; Luis Augusto Basso; Diogenes Santiago Santos; Eraldo L Batista
Journal:  Virchows Arch       Date:  2011-02-12       Impact factor: 4.064

6.  Transcriptional control of tight junction proteins via a protein kinase C signal pathway in human telomerase reverse transcriptase-transfected human pancreatic duct epithelial cells.

Authors:  Hiroshi Yamaguchi; Takashi Kojima; Tatsuya Ito; Yasutoshi Kimura; Masafumi Imamura; Seiichi Son; Jun-ichi Koizumi; Masaki Murata; Minoru Nagayama; Takayuki Nobuoka; Satoshi Tanaka; Koichi Hirata; Norimasa Sawada
Journal:  Am J Pathol       Date:  2010-06-21       Impact factor: 4.307

7.  Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor/Ras signaling and Ets transcription factors.

Authors:  Hanna B Kern; Brian F Niemeyer; Janet K Parrish; Carol A Kerr; Nasser K Yaghi; Jason D Prescott; Arthur Gutierrez-Hartmann; Paul Jedlicka
Journal:  DNA Cell Biol       Date:  2012-05-03       Impact factor: 3.311

8.  Elevated expression of p53 in early colon polyps in a pig model of human familial adenomatous polyposis.

Authors:  Krzysztof Flisikowski; Marek Switonski; Agata Sikorska; Tatiana Flisikowska; Monika Stachowiak; Alexander Kind; Angelika Schnieke
Journal:  J Appl Genet       Date:  2018-08-25       Impact factor: 3.240

9.  ETS-4 is a transcriptional regulator of life span in Caenorhabditis elegans.

Authors:  Bargavi Thyagarajan; Adam G Blaszczak; Katherine J Chandler; Jennifer L Watts; W Evan Johnson; Barbara J Graves
Journal:  PLoS Genet       Date:  2010-09-16       Impact factor: 5.917

10.  The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in ApcMin mice.

Authors:  Paul Jedlicka; Xiaomei Sui; Arthur Gutierrez-Hartmann
Journal:  BMC Cancer       Date:  2009-06-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.